Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
42,58 USD | -0,23 % | +7,56 % | -42,09 % |
08.05. | Transcript : QuidelOrtho Corporation, Q1 2024 Earnings Call, May 08, 2024 | |
08.05. | QuidelOrtho Corporation meldet Ergebnis für das erste Quartal zum 31. März 2024 | CI |
Kurzporträt
Mitarbeiterzahl: 7 100
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Busky
DFI | Director of Finance/CFO | 56 | - |
Louise Brandy
CTO | Chief Tech/Sci/R&D Officer | 65 | - |
Patrick Klein
ADM | Chief Administrative Officer | - | 01.05.22 |
Robert Bujarski
COO | Chief Operating Officer | 55 | 01.07.05 |
Werner Kroll
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Michael Iskra
PRN | Corporate Officer/Principal | 54 | 01.05.22 |
Michelle Hodges
LAW | General Counsel | - | 01.12.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Kenneth Widder
BRD | Director/Board Member | 71 | 01.01.14 |
Kenneth Buechler
CHM | Chairman | 70 | - |
Mary Polan
BRD | Director/Board Member | 80 | 01.01.93 |
Ann Rhoads
BRD | Director/Board Member | 58 | 01.01.20 |
Matthew Strobeck
BRD | Director/Board Member | 51 | 01.01.18 |
Edward Michael
BRD | Director/Board Member | 66 | 01.01.18 |
Evelyn Dilsaver
BRD | Director/Board Member | 68 | 01.01.22 |
Robert Schmidt
BRD | Director/Board Member | 41 | 01.01.22 |
Joseph Wilkins
BRD | Director/Board Member | 62 | 01.01.21 |
James Prutow
BRD | Director/Board Member | 55 | 28.11. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 66 878 683 | 53 475 787 ( 79,96 %) | 0 | 79,96 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. |
Medical Specialties
|
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. |
Medical Specialties
|
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-42,09 % | 2,85 Mrd. | |
-16,39 % | 18,51 Mrd. | |
+23,15 % | 1,95 Mrd. | |
+3,08 % | 1,72 Mrd. | |
+28,27 % | 1,26 Mrd. | |
-11,16 % | 1,02 Mrd. | |
-17,21 % | 950 Mio. | |
+0,07 % | 777 Mio. | |
-23,17 % | 643 Mio. | |
+11,79 % | 518 Mio. |
- Börse
- Aktien
- A3DNGX Aktie
- Unternehmen QuidelOrtho Corporation